COMPARATIVE BIOAVAILABILITY OF TRAZODONE FORMULATIONS USING STABLE ISOTOPE METHODOLOGY

被引：22

作者：

GAMMANS, RE

MACKENTHUN, AV

RUSSELL, JW

机构：

[1] BRISTOL MYERS PHARMACEUT RES & DEV,DEPT CLIN INFORMAT & STAT,EVANSVILLE,IN 47708

[2] MEAN COMPUCHEN,RES TRIANGLE PK,NC

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1984年 / 18卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1984.tb02485.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：431 / 437

页数：7

共 10 条

[1] TRAZODONE - A NEW ASSAY PROCEDURE AND SOME PHARMACOKINETIC PARAMETERS [J].

ANKIER, SJ ;

MARTIN, BK ;

ROGERS, MS ;

CARPENTER, PK ;

GRAHAM, C .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :505-509

[2]

Biocchi L., 1974, ARZNEIMITTELFORSCH, V24, P1699

[3] TRAZODONE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN DEPRESSION AND ANXIETY [J].

BROGDEN, RN ;

HEEL, RC ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1981, 21 (06) :401-429

[4] PLASMA-CONCENTRATIONS OF TRAZODONE AND 1-(3-CHLOROPHENYL) PIPERAZINE IN MAN AFTER A SINGLE ORAL DOSE OF TRAZODONE [J].

CACCIA, S ;

FONG, MH ;

GARATTINI, S ;

ZANINI, MG .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (09) :605-606

[5]

Catanese B, 1978, Boll Chim Farm, V117, P424

[6]

DEVLIN R, 1982, Clinical Pharmacology and Therapeutics, V31, P217

[7] BIOAVAILABILITY OF IMIPRAMINE TABLETS RELATIVE TO A STABLE ISOTOPE-LABELED INTERNAL STANDARD - INCREASING THE POWER OF BIOAVAILABILITY TESTS [J].

HECK, HDA ;

BUTTRILL, SE ;

FLYNN, NW ;

DYER, RL ;

ANBAR, M ;

CAIRNS, T ;

DIGHE, S ;

CABANA, BE .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (03) :233-248

[8]

JAUCH R, 1976, ARZNEIM FORSCH, V26, P204

[9] ANALYSIS OF 2-PERIOD REPEATED MEASUREMENTS CROSSOVER DESIGN WITH APPLICATION TO CLINICAL-TRIALS [J].

WALLENSTEIN, S ;

FISHER, AC .

BIOMETRICS, 1977, 33 (01) :261-269

[10] SYMMETRICAL CONFIDENCE-INTERVALS FOR BIOEQUIVALENCE TRIALS [J].

WESTLAKE, WJ .

BIOMETRICS, 1976, 32 (04) :741-744

← 1 →